Summit Global Investments - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$320
+47.5%
33,225
+62.5%
0.02%
+50.0%
Q2 2023$217
+55.0%
20,440
+53.7%
0.01%
+27.3%
Q1 2023$140
-15.2%
13,3000.0%0.01%
-21.4%
Q4 2022$165
-99.9%
13,300
+2.3%
0.01%
+16.7%
Q3 2022$135,000
-72.3%
13,000
-68.9%
0.01%
-61.3%
Q4 2021$487,000
-51.9%
41,742
-46.2%
0.03%
-59.2%
Q3 2021$1,013,000
+16.2%
77,542
+14.5%
0.08%
+46.2%
Q2 2021$872,000
+9.8%
67,742
-4.6%
0.05%
+2.0%
Q1 2021$794,00071,0420.05%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders